| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/24/2008 | WO2008088033A1 Hiv-protease inhibitor and method for production thereof |
| 07/24/2008 | WO2008088030A1 Composition for prevention or treatment of disease associated with thrombus or embolus |
| 07/24/2008 | WO2008088006A1 Ap2 inhibitor |
| 07/24/2008 | WO2008087933A1 NOVEL INDOLE DERIVATIVE HAVING INHIBITORY ACTIVITY ON IϰB KINASE β |
| 07/24/2008 | WO2008087882A1 Intragastric floating-type levodopa sustained-release preparation |
| 07/24/2008 | WO2008087862A1 Agent against periodontal disease |
| 07/24/2008 | WO2008087512A1 Morpholine dopamine agonists for the treatment of pain |
| 07/24/2008 | WO2008070552A3 Inhibitors of protein tyrosine phosphatase for the promotion of physiological cardiac hypertrophy |
| 07/24/2008 | WO2008055068A8 Inhibitors of histone deacetylase |
| 07/24/2008 | WO2008048691A3 Use of leptin for treating post-lipectomy ectopic fat deposition and other post-lipectomy associated disorders |
| 07/24/2008 | WO2008021375A3 Modulators of muscarinic receptors |
| 07/24/2008 | US20080177082 N3 alkylated benzimidazole derivatives as mek inhibitors |
| 07/24/2008 | US20080177071 Process for the preparation of 2- (2- (4- (bis (4-flourophenyl) methyl) -pipe razin-1-yl) ethoxy acetic acid derivatives or corresponding salt forms thereof and intermediates therefor |
| 07/24/2008 | US20080177064 Dipeptidyl peptidase inhibitors |
| 07/24/2008 | US20080177036 Selective Linear Peptides with Melanocortin-4 Receptor (MC4-R) Agonist Activity |
| 07/24/2008 | US20080176962 Methods and compositions for identifying cellular genes exploited by viral pathogens |
| 07/24/2008 | US20080176961 Phosphodiesterase acitvity and regulation of phosphodiesterase 1-B-mediated signaling in brain |
| 07/24/2008 | US20080176952 Management of Ophthalmologic Disorders, Including Macular Degeneration |
| 07/24/2008 | US20080176949 Form V can be formed by crystallization from various solvents rather than by sublimation; depression |
| 07/24/2008 | US20080176920 Neuronal Pain Pathway Modulators |
| 07/24/2008 | US20080176916 A-amino-n-hydroxy-acetamide derivatives |
| 07/24/2008 | US20080176910 Methods for prevention and treatment of arteriosclerosis and restenosis |
| 07/24/2008 | US20080176909 synergistic use of angiotensin II receptor antagonist like (5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]imidazol-5-carboxylate with the calcium channel blockers; calcium channel blockers containing 1,4-dihydropyridine group |
| 07/24/2008 | US20080176899 Such as 1-Benzo[1,3]dioxol-5-yl-cyclopropanecarboxylic acid [5-(2-methoxy-pyridin-3-ylmethyl)-thiazol-2-yl]-amide 5-(2-Methoxy-pyridin-3-ylmethyl)-thiazol-2-ylamine; cystic fibrosis transmembrane conductance regulator disorders |
| 07/24/2008 | US20080176897 Substituted Quinolone Carboxylic Acids, Their Derivatives, Site of Action, And Uses Thereof |
| 07/24/2008 | US20080176884 7,8-Saturated-4,5-Epoxy-Morphinanium Analogs |
| 07/24/2008 | US20080176849 e.g. N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]-amino]methyl]phenyl]-2E-2-propenamide; histone deacetylase inhibitor; anticarcinogenic, antitumor, antiproliferative agents; improved stability |
| 07/24/2008 | US20080176842 N1-[1-[N-(2-methylpropyl)-N-(phenylsulfonyl)amino]-2R-hydroxy-3S-(phenylmethyl)prop-3-yl]-3-(1-morpholinosulfonyl)-2R-methylpropionamide; viricide; human T-cell leukemia/limphoma virus |
| 07/24/2008 | US20080176820 Use of L-alpha-lysophosphatidylcholine to obtain the differentiation of monocytes into mature dendritic cells in vitro |
| 07/24/2008 | US20080176812 Allele-specific silencing of disease genes |
| 07/24/2008 | US20080176800 Methods for the delivery of bioactive substances with biodegradable polyphosphates |
| 07/24/2008 | US20080176797 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 07/24/2008 | US20080176790 mutants of fibroblast growth factors containing N-linked or O-linked glycosylation sites ;drug-polymer conjugates, used for treating fibroblast growth factor deficiency in patients |
| 07/24/2008 | US20080176788 Apo-2 ligand |
| 07/24/2008 | US20080176285 N-acetyl glucosamine phosphotransferase for use in treatment and prevention of lysosomal storage diseases |
| 07/24/2008 | US20080176259 Uses of carbamoyl phosphate synthetase 1 (cps 1) and it's fragments for the diagnosis of liver diseases |
| 07/24/2008 | US20080176243 Designing vector system comprising regulatory sequences which utilize human chorionic gonadotropin and/or nuclear factor kappaB as modulators of genic expression |
| 07/24/2008 | US20080176231 Apotosis inducing viral protein, in combination with defective p53 protein, for use in treatment of cell proliferative and autoimmune disorders |
| 07/24/2008 | US20080175971 Diagnostic And Therapeutic Epitope, And Transgenic Plant |
| 07/24/2008 | US20080175935 Method to Treat Skin Conditions with Narcissus Tazetta Bulb Extract |
| 07/24/2008 | US20080175910 Pharmaceutical dosage forms for controlled release producing at least a timed pulse |
| 07/24/2008 | US20080175883 Self-assembling peptide amphiphiles |
| 07/24/2008 | US20080175843 Nucleotide sequences coding osteoblast activating factor (OAF) for use in diagnosis, prevention and treatment of inflammatory, periodontal and infectious diseases |
| 07/24/2008 | US20080175842 Compositions and methods for treatment |
| 07/24/2008 | US20080175841 Antagonistic Anti-hTNFSF13b Human Antibodies |
| 07/24/2008 | US20080175839 Compositions Against Cancer Antigen LIV-1 and Uses Thereof |
| 07/24/2008 | US20080175838 Using alpha-synuclein specific monoclonal antibody to diagnose, prevent amd treat parkinson's disease |
| 07/24/2008 | US20080175834 Carboxypertidase U (Cpu) Mutants |
| 07/24/2008 | US20080175828 Proliferated cell lines and uses thereof |
| 07/24/2008 | US20080175818 Using replication-defective plasmid comprising p53 nucleotide sequences as as delivery tool for antitumor agents |
| 07/24/2008 | US20080175797 Preventing airway mucus production by administration of egf-r antagonists |
| 07/24/2008 | US20080175796 Delivery of Drug Esters Through an Inhalation Route |
| 07/24/2008 | US20080175791 Antitumor agents; immunosuppression; kits |
| 07/24/2008 | US20080175789 Prostate specific membrane antigen (PSMA); for diagnosis, detection and treatment of cancer; gene overexpression; kits |
| 07/24/2008 | US20080175788 Analyzing for changes in levels of cancer specific genes (CSG) in cells, tissues or bodily fluids compared with levels of CSG in preferably the same cells, tissues, or bodily fluid type of a normal human control: administering antibodies conjugated to cytotoxic agents, which specifically bind CSG |
| 07/24/2008 | DE102007003194A1 Verfahren zum Unterstützen und Ergänzen der Wirkung eines Saunabades A method of supporting and supplementing the action of a sauna bath |
| 07/24/2008 | CA2675968A1 Oligosaccharides comprising an aminooxy group and conjugates thereof |
| 07/24/2008 | CA2675836A1 Composition for preventing or treating thrombus- or embolus-associated disease |
| 07/24/2008 | CA2674865A1 Indole derivative having i.kappa.b kinase .beta. inhibitory activity |
| 07/24/2008 | CA2674678A1 Morpholine dopamine agonists for the treatment of pain |
| 07/24/2008 | CA2673485A1 Gastric retention-type sustained-release levodopa preparation |
| 07/23/2008 | EP1947178A1 Human monoclonal antibody binding to human gm-csf and antigen-binding site thereof |
| 07/23/2008 | EP1947175A1 Sequence of nucleotides and peptides gse 24.2 of dyskerin, which can induce telomerase activity, method for obtaining same, therapeutic compositions and applications thereof |
| 07/23/2008 | EP1947119A2 Treatment of cancer with anti-erb2 antibodies in combination with a chemotherapeutic agent |
| 07/23/2008 | EP1947117A2 Glycoprotein hormone superagonists |
| 07/23/2008 | EP1947111A1 Novel mucin glycoprotein and use thereof |
| 07/23/2008 | EP1947109A2 Biologically active peptides |
| 07/23/2008 | EP1947101A1 Hydrazide compound and thrombopoietin receptor activator |
| 07/23/2008 | EP1946765A1 Remedy for angiogenesis-related disease comprising chondromodulin-i as the active ingredient |
| 07/23/2008 | EP1946757A1 Atr inhibitor |
| 07/23/2008 | EP1945195A2 Novel use of a nutraceutical composition comprising resveratrol for the treatment of age-related diseases |
| 07/23/2008 | EP1562572B1 Pharmaceutical Solid Dispersions of Modafinil Compounds |
| 07/23/2008 | EP1490367B1 Imidazopyridine derivatives as kinase inhibitors |
| 07/23/2008 | EP1485145B1 Multiple compartment bag assembly containing dialysis fluid |
| 07/23/2008 | EP1412361B1 Substituted 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid derivatives serving as nmda antagonists |
| 07/23/2008 | EP1382603B1 Nitrogenous fused-ring compound having pyrazolyl group as substituent and medicinal composition thereof |
| 07/23/2008 | EP1372696B1 Methods for treating rheumatic diseases using a soluble ctla4 molecule |
| 07/23/2008 | EP1342723B1 Indole derivatives and use thereof in medicines |
| 07/23/2008 | EP1326607B1 Pharmaceutical compositions containing oxapenem-3-carboxilic acids |
| 07/23/2008 | EP1325745B1 Preventives and remedies for complications of diabetes |
| 07/23/2008 | EP1315715B1 Quinazoline derivatives as kinase inhibitors |
| 07/23/2008 | EP1278829B1 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 07/23/2008 | EP1218369B1 INHIBITORS OF c-JUN N-TERMINAL KINASES (JNK) AND OTHER PROTEIN KINASES |
| 07/23/2008 | EP1165797B1 Particles for gene therapy |
| 07/23/2008 | EP1141241B1 Adult human astrocytes, preparation of the same, and uses thereof |
| 07/23/2008 | EP1085876B1 Pharmaceutical composition with tumor necrosis factor a and 2-methoxyestrone-3-o-sulphamate for inhibition of estrone sulphatase |
| 07/23/2008 | EP1080092B1 Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation |
| 07/23/2008 | EP1073638B1 Heterocyclically substituted amides, their production and their use |
| 07/23/2008 | EP1071680B1 N,n-disubstituted amides that inhibit the binding of integrins to their receptors |
| 07/23/2008 | EP1047416B1 Pharmaceutical compositions comprising disulfiram for inhibiting angiogenesis |
| 07/23/2008 | EP0957914B2 Formulation of 5-ht agonists |
| 07/23/2008 | CN101228172A 6,7-unsaturated-7-carbamoyl substituted morphinan derivative |
| 07/23/2008 | CN101228144A Activator for peroxisome proliferator-activated receptor |
| 07/23/2008 | CN101228143A Thiazole derivative |
| 07/23/2008 | CN101224207A Medicine for inducing autophagy and treating disease caused by wrong unfolded protein aggregation, and filtration method thereof |
| 07/23/2008 | CN100405062C Therapeutic and diagnostic uses of antibody specificity profiles |
| 07/23/2008 | CN100404517C Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof |
| 07/23/2008 | CN100404511C 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzoazepine derivative or salt of the same |
| 07/23/2008 | CN100404505C Novel substituted indoles |
| 07/23/2008 | CN100404069C Application of edestin in preparation of anti-anoxia functional food |